284 filings
Page 2 of 15
SC 13G/A
CABA
Cabaletta Bio Inc
13 Feb 24
Cabaletta Bio / Bain Capital Life Sciences Opportunities III ownership change
6:47pm
SC 13G/A
CABA
Cabaletta Bio Inc
13 Feb 24
Cabaletta Bio / Nichtberger Steven ownership change
4:31pm
SC 13G/A
CABA
Cabaletta Bio Inc
12 Feb 24
Cabaletta Bio / Flynn James E ownership change
5:25pm
SC 13G/A
CABA
Cabaletta Bio Inc
7 Feb 24
Cabaletta Bio / ADAGE CAPITAL PARTNERS GP, L.L.C. ownership change
7:04am
8-K
CABA
Cabaletta Bio Inc
1 Feb 24
Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis
4:36pm
SC 13G
STT
State Street Corp.
24 Jan 24
Cabaletta Bio / STATE STREET ownership change
10:07am
4
Gwendolyn Binder
19 Jan 24
Cabaletta Bio / Gwendolyn Binder ownership change
6:30pm
SC 13G
CABA
Cabaletta Bio Inc
8 Jan 24
Cabaletta Bio / BlackRock ownership change
4:35pm
8-K
CABA
Cabaletta Bio Inc
8 Jan 24
Results of Operations and Financial Condition
7:11am
4
Gwendolyn Binder
19 Dec 23
Cabaletta Bio / Gwendolyn Binder ownership change
8:37pm
4
CABA
Cabaletta Bio Inc
21 Nov 23
Cabaletta Bio / Gwendolyn Binder ownership change
4:30pm
144
Gwendolyn Binder
20 Nov 23
Notice of proposed sale of securities
4:16pm
10-Q
2023 Q3
CABA
Cabaletta Bio Inc
Quarterly report
9 Nov 23
7:24am
8-K
CABA
Cabaletta Bio Inc
9 Nov 23
Cabaletta Bio Reports Third Quarter 2023 Financial Results and Provides Business Update
7:12am
8-K
CABA
Cabaletta Bio Inc
6 Nov 23
Cabaletta Bio Receives FDA Clearance of CABA-201 IND Application for Treatment of Generalized Myasthenia Gravis
7:03am
4
Gwendolyn Binder
19 Oct 23
Cabaletta Bio / Gwendolyn Binder ownership change
7:40pm
144
Gwendolyn Binder
19 Oct 23
Notice of proposed sale of securities
4:03pm
8-K
CABA
Cabaletta Bio Inc
2 Oct 23
Regulation FD Disclosure
7:38am
4
Gwendolyn Binder
20 Sep 23
Cabaletta Bio / Gwendolyn Binder ownership change
4:30pm
144
Gwendolyn Binder
19 Sep 23
Notice of proposed sale of securities
4:23pm